NCT06474221

Brief Summary

Our study is designed to study the efficacy of an Electronic based psycho-social intervention targeting healthy coping and problem solving skills to mitigate suicidal behaviour. This would integrate existing systems and bridge the gap in accessibility to care for suicidal behaviour.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
0mo left

Started Aug 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Aug 2024May 2026

First Submitted

Initial submission to the registry

June 18, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 25, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

August 31, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

1.6 years

First QC Date

June 18, 2024

Last Update Submit

February 4, 2026

Conditions

Keywords

Suicide attemptElectronic Based Psychosocal Intervention(EBPSI)

Outcome Measures

Primary Outcomes (2)

  • Persistent Suicide Ideation

    Change in intervention arm as compared to TAU on persistent suicidal ideation using the Columbia Suicide Severity Rating Scale (C-SSRS). the ideation ranges from 0-5 on this scale.

    At baseline and 1,3, 6 and 12 months after the baseline intervention.

  • Suicide attempts

    Change in intervention arm as compared to TAU on number of suicide attempts. Minimum attempts can be 0 and maximum can be infinity.

    At baseline and 1,3, 6 and 12 months after the baseline intervention.

Secondary Outcomes (5)

  • Depression

    At baseline and 1,3, 6 and 12 months after the baseline intervention.

  • Acceptability of Intervention Measure (AIM)

    At baseline and 1,3, 6 and 12 months after the baseline intervention.

  • Feasibility of Intervention Measure (FIM)

    At baseline and 1,3, 6 and 12 months after the baseline intervention.

  • Attribution Style

    At baseline and 1,3, 6 and 12 months after the baseline intervention.

  • Coping Mechanism

    At baseline and 1,3, 6 and 12 months after the baseline intervention.

Study Arms (2)

Electronic Based Psychosocial Intervention (EBPSI)

EXPERIMENTAL

Electronic Based Psychosocial Intervention (EBPSI) described as video based telepsychiatry sessions targeted on brief intervention and coping skills; with a total of 5 sessions on days 10, 30, 45, 60 and 90 after baseline intervention.

Behavioral: Electronic Based Psychosocial Intervention (EBPSI)

Treatment as Usual

ACTIVE COMPARATOR

The Treatment as Usual (TAU) arm shall be a telephonic regular contact: with a total of 5 reminder calls on days 10, 30, 45, 60 and 90 after baseline intervention. The session shall include a reminder for the next planned follow up session and a general query for overall wellbeing.

Behavioral: Electronic Based Psychosocial Intervention (EBPSI)

Interventions

Electronic based Psycho-social Intervention (EBPSI) described as video based telepsychiatry sessions targeted on brief intervention and coping skills; with a total of 5 sessions on days 10, 30, 45, 60 and 90 after baseline intervention.

Electronic Based Psychosocial Intervention (EBPSI)Treatment as Usual

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All adolescents who have attempted suicide within the last thirty days and presented to the study site
  • Between ages of 12-18 years
  • Participants of all gender will be included
  • Medically stable patients who have stable blood pressure, breathing rates without fever, and intact orientation to time, place, and person

You may not qualify if:

  • A current or a lifetime diagnosis of psychosis. We will confirm the same using a detailed clinical interview according to ICD-10 diagnostic guidelines.
  • A history of mental retardation and any neurological condition causing cognitive impairment.
  • A diagnosis of substance dependence as confirmed by M.I.N.I. KID 6.0 over the last six months. We will include those with tobacco dependence.
  • A diagnosis of serious medical illness like end-stage cancer, AIDS, less than a month following acute cardiovascular and cerebrovascular events.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

St John's Medical College and Hospital

Bengaluru, Karnataka, 560034, India

RECRUITING

Kalinga Institute of Medical Sciences (KIMS),

Bhubaneswar, Odisha, 751024, India

RECRUITING

MeSH Terms

Conditions

Suicide, Attempted

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Vishwajit L Nimgaonkar, MD, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vishwajit L Nimgaonkar, MD, PhD

CONTACT

Triptish Triptish, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The rater will be blind to the group status of the participant.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a multicentric, parallel arm, interventional randomized control trial. A total of 84 at each site will be enrolled, N = 168 would be adequate for both sites together.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 18, 2024

First Posted

June 25, 2024

Study Start

August 31, 2024

Primary Completion

March 31, 2026

Study Completion (Estimated)

May 31, 2026

Last Updated

February 9, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in the article, after deidentification (text, tables, figures, and appendices).

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
One year after publication of the results of the study.
Access Criteria
For individual participant data, meta-analysis.

Locations